1. Home
  2. ITOS vs BLDE Comparison

ITOS vs BLDE Comparison

Compare ITOS & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BLDE
  • Stock Information
  • Founded
  • ITOS 2011
  • BLDE 2014
  • Country
  • ITOS United States
  • BLDE United States
  • Employees
  • ITOS N/A
  • BLDE N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BLDE Aerospace
  • Sector
  • ITOS Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • ITOS 342.6M
  • BLDE 276.7M
  • IPO Year
  • ITOS 2020
  • BLDE N/A
  • Fundamental
  • Price
  • ITOS $8.32
  • BLDE $3.30
  • Analyst Decision
  • ITOS Strong Buy
  • BLDE Buy
  • Analyst Count
  • ITOS 3
  • BLDE 1
  • Target Price
  • ITOS $33.67
  • BLDE $6.00
  • AVG Volume (30 Days)
  • ITOS 543.4K
  • BLDE 691.4K
  • Earning Date
  • ITOS 11-12-2024
  • BLDE 11-12-2024
  • Dividend Yield
  • ITOS N/A
  • BLDE N/A
  • EPS Growth
  • ITOS N/A
  • BLDE N/A
  • EPS
  • ITOS N/A
  • BLDE N/A
  • Revenue
  • ITOS $35,000,000.00
  • BLDE $241,814,000.00
  • Revenue This Year
  • ITOS $271.18
  • BLDE $12.14
  • Revenue Next Year
  • ITOS N/A
  • BLDE $11.35
  • P/E Ratio
  • ITOS N/A
  • BLDE N/A
  • Revenue Growth
  • ITOS N/A
  • BLDE 12.04
  • 52 Week Low
  • ITOS $7.54
  • BLDE $2.45
  • 52 Week High
  • ITOS $18.75
  • BLDE $4.25
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 39.51
  • BLDE 44.54
  • Support Level
  • ITOS $7.54
  • BLDE $3.06
  • Resistance Level
  • ITOS $8.38
  • BLDE $3.76
  • Average True Range (ATR)
  • ITOS 0.53
  • BLDE 0.24
  • MACD
  • ITOS 0.01
  • BLDE -0.05
  • Stochastic Oscillator
  • ITOS 35.94
  • BLDE 26.09

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: